Protein intake, IGF-1 and osteoporosis

Osteoporosis International

Volumn 7, Issue SUPPL. 3, 1997, Pages

  Bonjour, J P ^a,b   Schurch M A ^a   Chevalley, T ^a   Ammann, P ^a   Rizzoli, R ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b University Hospitals   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031455673     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03194340     Document Type: Article

References (80)

1. Dawson Hughes B. The role of calcium in the treatment of osteoporosis. In: 'Osteoporosis' Marcus R, Feldman D, Kelsey J, editors. Osteoporosis San Diego: Academic Press, 1996:1159-68.
2. Orwoll ES. The effects of dietary protein insufficiency and excess on skeletal health. Bone 1992;13:343-50.
3. Bonjour JP, Schürch MA, Rizzoli R. Nutritional aspects of hip fractures. Bone 1996; 18 (Suppl): S139-44.
4. Recommended Daily Allowances. National Research Council (US). 10th ed. Washington, DC: National Academy Press, 1989.
5. Pellett PL. Protein requirements in humans. Am J Clin Nutr 1990;51:723-37.
6. Canalis E, Agnusdei D. Insulin-like growth factors and their role in osteoporosis. Calcif Tissue Int 1996;58:133-4.
7. Rosen C. Growth hormone, insulin-like growth factors, and the senescent skeleton: Ponce de Leon's fountain revisited? J Cell Biochem 1994;56:348-56.
8. Rosen CJ, Donahue LR. Insulin-like growth factors: potential therapeutic options for osteoporosis. Trends Endocrinol Metab 1995;6:235-41.
9. Isley WL, Underwood LE, Clemmons DR. Dietary components that regulate serum somatomedin-C concentrations in humans. J Clin Invest 1983;71:175-82.
10. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994;15:80-101.
11. Thissen JP, Triest S, Maes M, Underwood LE, Ketelslegers JM. The decreased plasma concentrations of insulin-like growth factor-1 in protein-restricted rats is not due to decreased number of growth hormone receptors on isolated hepatocytes. J Endocrinol 1990;124:159-65.
12. VandeHaar MJ, Moats-Staats BM, Davenport ML, Walker JL, Ketelslegers JM, Sharma BK, et al. Reduced serum concentrations of insulin-like growth factor-1 in protein-restricted growing rats are accompanied by reduced IGF-1 mRNA levels in liver and skeletal muscle. J Endocrinol 1991;130:305-12.
13. 125I)-labeled IGF-1 in protein-restricted rats. Am J Physiol 1992;262:E406-11.
14. Thissen JP, Triest S, Moats-Staats BM, et al. Evidence that pretranslational and translational defects decrease serum insulin-like growth factor-1 concentrations during dietary protein restriction. Endocrinology 1991;129:429-35.
15. Maiter D, Fliesen T, Underwood LE, Maes M, Gerard G, Davenport ML, et al. Dietary protein restriction decreases insulin-like growth factor-1 independent of insulin and liver growth hormone binding. Endocrinology 1989;124:2604-11.
16. Straus DS, Takemoto CD. Effect of dietary protein deprivation on insulin-like growth factor (IGF)-I and (IGF)-II, IGF binding protein-2, and serum albumin gene expression in rat. Endocrinology 1990;127:1849-60.
17. Harp JB, Goldstein S, Phillips LS. Molecular regulation of IGF-1 by amino acid availability in cultured hepatocytes. Diabetes 1991;40:95-101.
18. Pucilowska JB, Davenport ML, Kabir I, et al. The effect of dietary protein supplementation on insulin-like growth factors (IGFs) and IGF-binding proteins in children with shigellosis. J Clin Endocrinol Metab 1993;77:1516-21.
19. Hill KK, Hill DB, McClain MP, Humphries LL, McClain CJ. Serum insulin-like growth factor-1 concentrations in the recovery of patients with anorexia nervosa. J Am Coll Nutr 1993;4:475-8.
20. Ketelslegers JM, Maiter D, Maes M, Underwood LE, Thissen JP. Nutritional regulation of insulin-like growth factor-1. Metabolism 1995;44:50-7.
21. Clemmons DR, Underwood LE, Dickerson RN, et al. Use of plasma somatomedin-C/insulin-like growth factor-1 measurements to monitor the response to nutritional repletion on malnourished patients. Am J Clin Nutr 1985;41:191-8.
22. Thissen JP, Underwood LE, Maiter D, Maes M, Clemmons DR, Ketelslegers JM. Failure of insulin-like growth factor-1 (IGF-1) infusion to promote growth in protein-restricted rats despite normalization of serum IGF-1 concentrations. Endocrinology 1991;128:885-90.
23. 3. Endocrinology 1990;126:2088-94.
24. Rosen C, Donahue LR, Hunter S, Holick M, Kavookjian H, Kirschenbaum A, et al. The 24/25-kDa serum insulin-like growth factor-binding protein is increased in elderly women with hip and spine fractures. J Clin Endocrinol Metab 1992;74:24-7.
25. Straus DS, Burke EJ, Marten NW. Induction of insulin-like growth factor binding protein-1 gene expression in liver of protein-restricted rats and in rat hepatoma cells limited for a single amino acid. Endocrinology 1993;132:1090-100.
26. Smith WJ, Underwood LE, Clemmons DR. Effects of caloric or protein restriction on insulin-like growth factor-1 (IGF-1) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab 1995;80:443-9.
27. Schürch MA, Rizzoli R, Vadas L, Slosman DO, Bonjour JP. Protein supplements in elderly with a recent hip fracture increase serum IGF-1, decrease urinary deoxypyridinoline, and prevent proximal femur bone loss. J Bone Miner Res 1996;11(Suppl 1): S139.
28. Froesch ER, Schmid C, Schwander J, Zapf J. Actions of insulin-like growth factors. Annu Rev Physiol 1985;47:443-67.
29. Canalis E, McCarthy TL, Centrella M, Growth factors and cytokines in bone cell metabolism. Annu Rev Med 1991;42:17-24.
30. Schmid C, Ernst M. Insulin-like growth factors. In: Gowen M, editor. Cytokines and bone metabolism. Boca Raton, FL: CRC Press, 1992:229-65.
31. 3. Endocrinology 1990;127:453-9.
32. i transport activity in osteoblast-like cells. J Bone Miner Res 1990;5(Suppl 2):S228.
33. Palmer G, Bonjour JP, Caverzasio J. Stimulation of inorganic phosphate transport by insulin-like growth factor-1 and vanadate ipossum kidney cells is mediated by distinct protein tyrosine phosphorylation processes. Endocrinology 1996;137:4699-705.
34. Daughaday WH, Trivedi B. Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism). Proc Natl Acad Sci USA 1987;84:4636-40.
35. Merimee TJ, Zapf J, Hewlett B, Cavalli-Sforza LL. Insulin-like growth factors in pygmies. N Engl J Med 1987;316:906-11.
36. Hyer SL, Rodin DA, Tobias JH, Leiper A, Nussey SS. Growth hormone deficiency during puberty reduces adult bone mineral density. Arch Dis Child 1992;67:1472-4.
37. Saggese G, Baroncelli GI, Bertelloni S, Barsanti S. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency: role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 1996;81:3077-83.
38. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S. Genetic determinants of bone mass in adults: a twin study. J Clin Invest 1987;80:706-10.
39. Kao PC, Matheny AP Jr, Lang CA. Insulin-like growth factor-1 comparisons in healthy twin children. J Clin Endocrinol Metab 1994;78:310-2.
40. Ammann P, Rizzoli R, Muller K. Slosman D, Bonjour JP. IGF-1 and pamidronate increase bone mineral density in ovariectomized adult rats. Am J Physiol 1993;265:E770-6.
41. Ammann P, Rizzoli R, Meyer JM, Bonjour JP. Bone density and shape as determinants of bone strength in IGF-1 and/or pamidronate-treated ovariectomized rats. Osteoporos Int 1996;6:219-27.
42. Underwood LE. Reduced serum concentrations of insulin-like growth factor-1 (IGF-1) in protein-restricted growing rats are accompanied by reduced IGF-1 mRNA levels in liver and skeletal muscle. J Endocrinol 1991;130:305-12.
43. Cohick WS, Clemmons DR. the insulin-like growth factors. Annu Rev Physiol 1993;55:131-53.
44. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34.
45. Chevalley T, Rizzoli R, Manen D, Caverzasio J, Bonjour JP. Arginine increases IGF-1 production and collagen synthesis in osteoblastic cells. J Bone Miner Res 1996;11(Suppl 1):S375.
46. Bachrach LK. Osteopenia in childhood and adolescence. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. San Diego: Academic Press, 1996:785-800.
47. Ferretti JL, Tessaro RD, Delgado CJ, Bozzini CE, Alippi RM, Barcelo AC. Biochemical performance of diaphyseal shafts and bone tissue of femur from protein-restricted rats. Bone Miner 1988;4:329-39.
48. Clavien H, Theintz G, Rizzoli R, Bonjour JP. Does puberty alter dietary habits in adolescents living in a Western society? J Adolescent Health 1996;19:68-75.
49. Bonjour JP, Theintz G, Buchs B, Slosman D, Rizzoli, R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991;73:555-63.
50. Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, Sizonenko PC, et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spiine and femoral neck in female subjects. J Clin Endocrinol Metab 1992;75:1060-5.
51. Bonjour JP, Theintz G, Law F, Slosman D, Rizzoli R. Peak bone mass. Osteoporos Int 1994; 4(Suppl 1):7-14.
52. Geinoz G, Rapin CH, Rizzoli R, Kraemer R, Buchs B, Slosman D, et al. Relationship between bone mineral density and dietary intakes in the elderly. Osteoporos Int 1993;3:242-8.
53. Garn SM, Guzman MA, Wagner B. Subperiostal gain and endosteal loss in protein-calorie malnutrition. Am J Phys Anthropol 1969;30:153-5.
54. Parfitt AM, Miller MJ, Frame B, et al. Metabolic bone disease after intestinal bypass for treatment of obesity. Ann Intern Med 1978;89:193-200.
55. Seeman E, Riggs BL. Dietary prevention of bone loss in the elderly. Geriatrics 1981;36:71-9.
56. Garn SM, Kanzas J. Protein intake, bone mass, and bone loss. In: De Luca HF, Frost H, Jee W, Johnston C, Parfitt AM, editors. Osteoporosis: recent advances in pathogenesis and treatment. Baltimore: University Park Press, 1981:257-63.
57. Parfitt AM. Dietary risk factors for age-related bone loss and fractures. Lancet 1983;II:1181-4.
58. Schaafsma G, Van Beresteyn ECH, Raymakers JA, Duursma SA. Nutritional aspects of osteoporosis. World Rev Nutr Diet 1987;49:121-59.
59. Young GA, Chem C, Hill GL. Assessment of protein-calorie malnutrition in surgical patients from plasma proteins and anthropometric measurements. Am J Clin Nutr 1978;31:429-35.
60. Wooton RR, Brereton PJ, Clark MB, Hesp R, Hodkinson HM, Klenerman L, et al. Fractured neck of femur in the elderly: an attempt to identify patients at risk. Clin Sci 1979;57:93-101.
61. Rapin CH, Lagier R, Boivin G, Jung A, MacGee W. Biochemical findings in blood of aged patients with femoral neck fractures: a contribution to the detection of occult osteomalacia. Calcif Tissue Int 1982;34:465-9.
62. Bastow MD, Rawlings J, Allison SP. Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. BMJ 1983;287:1589-92.
63. Bastow MD, Rawlings J, Allison SP. Undernutrition, hypothermia, and injury in elderly women with fractured femur: an injury response to altered metabolism? Lancet 1983;I:143-6.
64. Giaccaglia G, Malagu U, Antonelli M, Boschi S, Tabarroni I. Il supporto nutrizionale negli interventi di fratture dell'anca, nell'anziano: esperienze e risultati. Minerva Anesthesiol 1986;52:397-400.
65. Tinetti ME, Speechley M, Ginter SF. Risks factors for falls among elderly persons living in the community. N Engl J Med 1988;319:1701-7.
66. Delmi M, Rapin CH, Bengoa JM, Delmas PD, Vasey H, Bonjour JP. Dietary supplementation in elderly patients with fractured neck of the femur. Lancet 1990;335:1013-6.
67. Patterson BM, Cornell CN, Carbone B, Levine B, Chapman D. Protein depletion and metabolic stress in elderly patients who have a fracture of the hip. J Bone Joint Surg Am 1992;74:251-60.
68. Chevalley T, Rizzoli R, Nydegger V, Slosman D, Tkatch L, Rapin CH, et al. Preferential low bone mineral density of the femoral neck in patients with a recent fracture of the proximal femur. Osteoporos Int 1991;1:147-54.
69. Dawson-Hughes B. Calcium supplementation and bone loss: a review of controlled clinical trials. Am J Clin Nutr 1991;54:S274-80.
70. 3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637-42.
71. Chevalley T, Rizzoli R, Nydegger V, Slosman D, Rapin CH, Michel JP, et al. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin D-replete elderly patients. Osteoporos Int 1994;4:245-52.
72. Morley JE, Miller DK. Malnutrition in the elderly. Hospital Practice 1992;27:95-116.
73. Munro H, Schlierf G. Nutrition of the elderly. Nestlé nutrition workshop series, 29. New York: Raven Press, 1992.
74. Hammerman MR. Insulin-like growth factors and aging. Endocrinol Metab Clin 1987;16:995-1011.
75. Quesada JM, Coopmans W, Ruiz B, Aljama P, Jans I, Bouillon R. Influence of vitamin D on parathyroid function in the elderly. J Clin Endocrinol Metab 1992;75:494-501.
76. Schüren MA, Rizzoli R, Mermillod B, Vasey H, Michel JP, Bonjour JP. A prospective study on socioeconomic aspects of fracture of the proximal femur. J Bone Miner Res 1996;11:1935-42.
77. Sullivan DH, Patch GA, Walls RC, Lipschitz DA. Impact of nutrition status on morbidity in a select population of geriatric rehabilitation patients. Am J Clin Nutr 1990;51:749-58.
78. Tkatch L, Rapin CH, Rizzoli R, Slosman D, Nydegger V, Vasey, H, et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. J Am Coll Nutr 1992;11:519-25.
79. Sullivan DH, Carter WJ. Insulin-like growth factor-1 as an indicator of protein-energy undernutrition among metabolically stable hospitalized elderly. J Am Coll Nutr 1994; 13:184-91.
80. Bonjour JP, Rizzoli R. Inadequate protein intake and osteoporosis: possible involvement of the IGF system. In: Burckhardt P, Heaney RP, editors. Challenges of modern medicine: nutritional aspects of osteoporosis '94, vol 7. Ares-Serono Symposia Publications 1995:399-406.